How to pay the least
From
$26.97 for 30 tablets
Generic cefpodoxime proxetil with the free Team Cuban Card, at pharmacies that take it. Pick the strength on your label for its own price.
What to do
- Get the free Team Cuban Card. It costs nothing to sign up.See the price and get the card
- At a pharmacy that takes it, show the card and ask for generic cefpodoxime proxetil.Find a pharmacy that takes it
Other ways
By mail, if you can wait a few days From $22.33 for 30 tablets delivered ($17.08 plus $5.25 shipping) from Cost Plus Drugs. Make a free account, then have your prescription sent there.
Open Cost Plus DrugsEvery company’s cefpodoxime proxetil is rated by the FDA to work the same, so any pharmacy can fill your prescription with the one it stocks.
Where to buy it
Pharmacies’ own cash prices for generic cefpodoxime proxetil, lowest first.
Pick up in storeDelivered
- Delivered: Cost Plus Drugs from $17.08for 30 tablets100 mg $17.08 · 200 mg $30.56Plus $5.25 shipping
- Pick up in store: Team Cuban Card from $26.97for 30 tablets100 mg $26.97 · 200 mg $39.29Free card · Kroger, Albertsons, Safeway, Meijer and many local pharmaciesFind a pharmacy that takes it
- Delivered: Amazon Pharmacy from $14.22for 7 tablets100 mg: $14.22 for 7 tablets200 mg: $6.38 for 3 tabletsPrime members only · $139 a year · Free delivery · Prime price: limits on some medicines if you're over 65 or have Medicare, Medicaid or TRICARE
- Pick up in store: Costco $33.99for 14 tablets200 mgMembers only · $65 a yearFind the nearest store
- Delivered: Rx Outreach from $18for 7 tablets100 mg: $18 for 7 tablets · each additional 7 tablets: $5200 mg: $20 for 7 tablets · each additional 7 tablets: $10Free delivery
- Pick up in store: Sam's Club See its pricePlus members only · $120 a yearFind the nearest store
From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.
About these prices
Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.
Who makes it
5 companies sell cefpodoxime proxetil in this form, each one rated by the FDA as a substitute for the others. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
-
Amici Pharma100 mg, 200 mg
Has lactose · Has dyes: FD&C Yellow No. 5, FD&C Yellow No. 6 · Made by Alkem Laboratories
How it looks, what’s in it, NDCs
100 mg Orange, oval, 12 mm, marked “A55”
Package NDC Bottle of 100 69292-514-01 Bottle of 500 69292-514-50 200 mg Orange, capsule, 16 mm, marked “A57”
Package NDC Bottle of 100 69292-516-01 Bottle of 500 69292-516-50 Inactive ingredients: carboxymethylcellulose calcium, silicon dioxide, crospovidone, FD&C Yellow No. 5, FD&C Yellow No. 6, hydroxypropyl cellulose, hypromelloses, ferric oxide red, lactose monohydrate, polyethylene glycol, magnesium stearate, sodium lauryl sulfate, titanium dioxide
-
Ascend Laboratories100 mg, 200 mg
Has lactose · Has a dye: FD&C Yellow No. 6 · Made by Alkem Laboratories
How it looks, what’s in it, NDCs
100 mg Orange, oval, 12 mm, marked “A55”
Package NDC Bottle of 20 67877-878-20 Bottle of 100 67877-878-01 Bottle of 500 67877-878-05 200 mg Orange, capsule, 16 mm, marked “A57”
Package NDC Bottle of 20 67877-879-20 Bottle of 100 67877-879-01 Bottle of 500 67877-879-05 Inactive ingredients: carboxymethylcellulose calcium, silicon dioxide, crospovidone, FD&C Yellow No. 6, hydroxypropyl cellulose, hypromelloses, ferric oxide red, lactose monohydrate, polyethylene glycol, magnesium stearate, sodium lauryl sulfate, titanium dioxide
-
Aurobindo Pharma100 mg, 200 mg
Has lactose · Has dyes: FD&C Yellow No. 6, FD&C Red No. 40
Product page on aurobindousa.com
How it looks, what’s in it, NDCs
100 mg Light Yellowish-Orange, oval, 11 mm, marked “C / 61”
Package NDC Bottle of 20 65862-095-20 Bottle of 100 65862-095-01 Bottle of 250 65862-095-25 Bottle of 1000 65862-095-99 200 mg Coral Red, oval, 15 mm, marked “C / 62”
Package NDC Bottle of 20 65862-096-20 Bottle of 100 65862-096-01 Bottle of 250 65862-096-25 Bottle of 1000 65862-096-99 Inactive ingredients: carboxymethylcellulose calcium, lactose monohydrate, hydroxypropyl cellulose (1600000 wamw), sodium lauryl sulfate, crospovidone (120 .mu.m), starch, corn, magnesium stearate, hypromellose 2910 (6 mpa.s), titanium dioxide, propylene glycol, FD&C Yellow No. 6, ferric oxide yellow, FD&C Red No. 40
-
NorthStar Rx100 mg, 200 mg
Has lactose · Has dyes: FD&C Yellow No. 6, FD&C Red No. 40 · Made by Aurobindo Pharma
Product page on northstarrxllc.com
How it looks, what’s in it, NDCs
100 mg Light Yellowish-Orange, oval, 11 mm, marked “C / 61”
Package NDC Bottle of 20 16714-394-01 200 mg Coral Red, oval, 15 mm, marked “C / 62”
Package NDC Bottle of 20 16714-395-01 Inactive ingredients: carboxymethylcellulose calcium, lactose monohydrate, hydroxypropyl cellulose (1600000 wamw), sodium lauryl sulfate, crospovidone (15 mpa.s at 5%), starch, corn, magnesium stearate, hypromellose 2910 (6 mpa.s), titanium dioxide, propylene glycol, FD&C Yellow No. 6, ferric oxide yellow, FD&C Red No. 40
-
Sandoz100 mg, 200 mg
Has lactose · Has a dye: FD&C Yellow No. 6
How it looks, what’s in it, NDCs
100 mg Light orange, oval, 16 mm, marked “SZ / 438”
Package NDC Bottle of 20 0781-5438-20 Bottle of 100 0781-5438-01 200 mg Light orange, oval, 16 mm, marked “SZ / 439”
Package NDC Bottle of 20 0781-5439-20 Bottle of 100 0781-5439-01 Inactive ingredients: carboxymethylcellulose calcium, crospovidone (15 mpa.s at 5%), FD&C Yellow No. 6, hydroxypropyl cellulose (1600000 wamw), hypromellose, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, talc, titanium dioxide
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
What to say at the pharmacy
“Before you fill it, what would I pay for generic cefpodoxime proxetil?”
Paying cash? Ask for the cash price. With insurance, ask what your plan charges.
What it’s used for
- Ear infections
- Sinus infections
- Throat and tonsil infections
- Urinary tract infections
- Pneumonia
- Flare-ups of chronic bronchitis
- Skin infections
- Gonorrhea
What the FDA label says
Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Recommended dosages, durations of therapy, and applicable patient populations vary among these infections. Please see DOSAGE AND ADMINISTRATION for specific recommendations. Acute otitis media caused by Streptococcus pneumoniae (excluding penicillin-resistant strains), Streptococcus pyogenes, Haemophilus influenzae (including beta-lactamase-producing strains), or Moraxella (Branhamella) catarrhalis (including beta-lactamase-producing strains). Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes. NOTE: Only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. Cefpodoxime proxetil is generally effective in the eradication of streptococci from the oropharynx. However, data establishing the efficacy of cefpodoxime proxetil for the prophylaxis of subsequent rheumatic fever are not available. Community-acquired pneumonia caused by S. pneumoniae or H. Influenzae (including beta-lactamase-producing strains). Acute bacterial exacerbation of chronic bronchitis caused by S. pneumoniae, H. influenzae (non-beta-lactamase-producing strains only), or M. catarrhalis. Data are insufficient at this time to establish efficacy in patients with acute bacterial exacerbations of chronic bronchitis caused by beta-lactamase-producing strains of H. influenzae. Acute, uncomplicated urethral and cervical gonorrhea caused by Neisseria gonorrhoeae (including penicillinase-producing strains). Acute, uncomplicated ano-rectal infections in women due to Neisseria gonorrhoeae (including penicillinase-producing strains). NOTE: The efficacy of cefpodoxime in treating male patients with rectal infections caused by N. gonorrhoeae has not been established. Data do not support the use of cefpodoxime proxetil in the treatment of pharyngeal infections due to N. gonorrhoeae in men or women. Uncomplicated skin and skin structure infections caused by Staphylococcus aureus (including penicillinase-producing strains) or Streptococcus pyogenes. Abscesses should be surgically drained as clinically indicated. NOTE: In clinical trials, successful treatment of uncomplicated skin and skin structure infections was dose-related. The effective therapeutic dose for skin infections was higher than those used in other recommended indications. (See DOSAGE AND ADMINISTRATION.) Acute maxillary sinusitis caused by Haemophilus influenzae (including beta-lactamase-producing strains), Streptococcus pneumoniae, and Moraxella catarrhalis. Uncomplicated urinary tract infections (cystitis) caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, or Staphylococcus saprophyticus. NOTE: In considering the use of cefpodoxime proxetil in the treatment of cystitis, cefpodoxime proxetil’s lower bacterial eradication rates should be weighed against the increased eradication rates and different safety profiles of some other classes of approved agents. (See CLINICAL STUDIES section.) Appropriate specimens for bacteriological examination should be obtained in order to isolate and identify causative organisms and to determine their susceptibility to cefpodoxime. Therapy may be instituted while awaiting the results of these studies. Once these results become available, antimicrobial therapy should be adjusted accordingly. To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefpodoxime proxetil and other antibacterial drugs, cefpodoxime proxetil should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Source: the FDA label for Cefpodoxime (NorthStar Rx LLC), January 3, 2024. Full label on DailyMed
Good to know
- Different companies’ cefpodoxime proxetil can look different. The FDA requires each to work the same way.
- Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/cefpodoxime/